BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4308481)

  • 1. Hypothalamic control of ACTH release from ectopic pituitary glands.
    Sirett NE; Kendall JW
    Endocrinology; 1969 Oct; 85(4):784-8. PubMed ID: 4308481
    [No Abstract]   [Full Text] [Related]  

  • 2. Site of corticotropin-releasing factor (CRF) releasing elements: effect of lesions on ACTH release and adenohypophysial blood flow.
    Porter JC
    Endocrinology; 1969 Jun; 84(6):1398-403. PubMed ID: 4305943
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the glucocorticoid feedback control of ACTH secretion.
    Kendall JW; Allen C
    Endocrinology; 1968 Feb; 82(2):397-405. PubMed ID: 4378097
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of selective surgical interruption of the anterior pituitary's blood supply on ACTH release.
    Porter JC; Mical RS; Tippit PR; Drane JW
    Endocrinology; 1970 Mar; 86(3):590-9. PubMed ID: 4312113
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypothalamus and pituitary ACTH release.
    Hodges JR
    Prog Brain Res; 1970; 32():12-20. PubMed ID: 4321514
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of assays for corticotrophin-releasing activity.
    Chan LT; de Wied D; Saffran M
    Endocrinology; 1969 Apr; 84(4):967-72. PubMed ID: 4304035
    [No Abstract]   [Full Text] [Related]  

  • 9. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotrophin secretion by ectopic pituitary glands.
    Purves HD; Sirett NE
    Endocrinology; 1967 May; 80(5):962-8. PubMed ID: 4290306
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
    Karanth S; Linthorst AC; Stalla GK; Barden N; Holsboer F; Reul JM
    Endocrinology; 1997 Aug; 138(8):3476-85. PubMed ID: 9231802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of cerebrospinal fluid circulation to the ACTH-suppressing effects of corticosteroid implants in the rat brain.
    Kendall JW; Grimm Y; Shimshak G
    Endocrinology; 1969 Aug; 85(2):200-8. PubMed ID: 4306597
    [No Abstract]   [Full Text] [Related]  

  • 13. Pituitary vascularity and ACTH release in rats with hypothalamic lesions.
    Upton GV; Brodish A
    Yale J Biol Med; 1968 Oct; 41(2):212-25. PubMed ID: 4303347
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of moderate and intensive training on the hypothalamo-pituitary-adrenal axis in rats.
    Chennaoui M; Gomez Merino D; Lesage J; Drogou C; Guezennec CY
    Acta Physiol Scand; 2002 Jun; 175(2):113-21. PubMed ID: 12028131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities in the hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats during development of hypertension.
    Hashimoto K; Makino S; Hirasawa R; Takao T; Sugawara M; Murakami K; Ono K; Ota Z
    Endocrinology; 1989 Sep; 125(3):1161-7. PubMed ID: 2547578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
    Dallman MF; Makara GB; Roberts JL; Levin N; Blum M
    Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor.
    Muret L; Priou A; Oliver C; Grino M
    Endocrinology; 1992 May; 130(5):2725-32. PubMed ID: 1315256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Central nervous system and the secretion of ACTH (a review of the literature)].
    Kolebinov NKhr
    Vutr Boles; 1973; 12(2):7-15. PubMed ID: 4351498
    [No Abstract]   [Full Text] [Related]  

  • 20. ACTH secretion due to hypothalamo-pituitary effects of adenosine 3',5'-monophosphate and related substances.
    Hedge GA
    Endocrinology; 1971 Aug; 89(2):500-6. PubMed ID: 4326792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.